A comparison of three scales for assessing social functioning in primary care

American Journal of Psychiatry

Volumn 158, Issue 3, 2001, Pages 460-466

  Weissman, M M ^a   Olfson, M ^a   Gameroff, M J ^a   Feder, A ^a   Fuentes, M ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CORRELATION FUNCTION; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RATING SCALE; RESEARCH; SELF REPORT; SOCIAL INTERACTION;

ADULT; AGED; DEPRESSIVE DISORDER; FEMALE; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PERSONALITY INVENTORY; PRIMARY HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUESTIONNAIRES; SOCIAL ADJUSTMENT;

EID: 0035092025     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.3.460     Document Type: Article

References (24)

1. Depression, disability days, and days lost from work in a prospective epidemiologic survey
2. The economic burden of depression in 1990
3. The functioning and well-being of depressed patients: Results from the Medical Outcomes Study
4. The treatment of chronic depression, part 3: Psychosocial functioning before and after treatment with sertraline or imipramine
5. Treatments of depression and the functional capacity to work
6. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: Psychosocial outcomes
7. Assessing psychiatric impairment in primary care with the Sheehan Disability Scale
8. Assessment of social functioning in depression
9. Development and validation of a social functioning scale, the Social Adaptation Self-Evaluation Scale
10. The MOS 36-Item Short-Form Health Survey (SF-36), I: Conceptual framework and item selection
11. Assessment of social adjustment by patient self-report
12. The clinical pharmacologic profile of reboxetine: Does it involve the putative neurobiological substrates of wellbeing?
13. Noradrenaline-selective versus serotonin-selective antidepressant therapy: Differential effects on social functioning
14. Prevalence of anxiety, depression, and substance use disorders in an urban general medicine practice
15. Social adjustment by self-report in a community sample and in psychiatric outpatients
16. Do noradrenaline and serotonin differentially affect social motivation and behaviour?
17. Readability of self-report clinical outcome measures